Aleksander WardęSzkiewicz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Aleksander WardęSzkiewicz has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Adam Durczyński
Department of General and Transplant Surgery, Medical University of Lodz, 90-419 Lodz, Poland
2 shared publications - Janusz Strzelczyk
Department of General and Transplant Surgery, Medical University of Lodz, 90-419 Lodz, Poland
2 shared publications - Oliwia Grząsiak-Kraj
Department of General and Transplant Surgery, Medical University of Lodz, 90-419 Lodz, Poland
2 shared publications - Alicja Majos
Department of General and Transplant Surgery, Norbert Barlicki University Hospital, Medical University of Łódź, 90-153 Łódź, Poland
1 shared publication - Alicja Majos
Department of General and Transplant Surgery, Medical University of Lodz, 90-419 Lodz, Poland
1 shared publication - Aneta Szmiel
Department of General and Transplant Surgery, Medical University of Lodz, 90-419 Lodz, Poland
1 shared publication
Latest Publications
- Open Access
Simple Algorithm for Blood Morphology Analysis (SAMBA): An Artificial Intelligence-Assisted Approach to Identify Peripheral Blood Phenotypes in a Cohort of Patients with Pancreatic Ductal Adenocarcinoma (PDAC)
Introduction: Eosinophils have become important therapeutic targets in several allergic diseases. This study aimed to apply a similar approach—using peripheral blood findings to identify features of type 2 (T2) inflammation—to oncology. We used Simple Algorithm for Blood Morphology Analysis (SAMBA) to describe blood count profiles in a cohort of patients with PDAC independently of relative ratios and propose a potential classification. Materials and Methods: We included 153 treatment-naïve patients with PDAC confirmed by postoperative histopathology. Of these, n = 68 (44.4%) underwent curative surgery, whereas n = 85 (55.6%) received palliative treatment or underwent surgical biopsy only. SAMBA was applied using laboratory reference ranges and overall survival (OS; months) as the analytical context. Results: The subgroups defined according to laboratory reference ranges did not differ significantly in disease stage, grade, or resection status. Based on correlation analyses, Kaplan–Meier curves, and a classification and regression tree (CART) analysis of OS, we propose four blood count phenotypes: exhausted, lymphopenic, T2-low, and T2-high (median OS: 1.5 months, n = 22; 4.5 months, n = 12; 8.0 months, n = 25; and 10.0 months, n = 94, respectively). Conclusions: We propose the following preliminary interpretations of these phenotypes: exhausted, potentially associated with concomitant infection or marked inflammation; lymphopenic, characterized by a low lymphocyte count and potentially reduced antitumor immune activity; eosinopenic (T2-low), characterized by a relatively balanced inflammatory profile but limited T2-associated features; and eosinophilic (T2-high), characterized by no major abnormalities in the other blood count parameters and a more favorable prognosis. SAMBA is a transparent, readily interpretable algorithm that may help standardize and accelerate preliminary research in immuno-oncology.
Open AccessSimple Algorithm for Blood Morphology Analysis (SAMBA): An Artificial Intelligence-Assisted Approach to Identify Peripheral Blood Phenotypes in a Cohort of Patients with Pancreatic Ductal Adenocarcinoma (PDAC)
Introduction: Eosinophils have become important therapeutic targets in several allergic diseases. This study aimed to apply a similar approach—using peripheral blood findings to identify features of type 2 (T2) inflammation—to oncology. We used Simple Algorithm for Blood Morphology Analysis (SAMBA) to describe blood count profiles in a cohort of patients with PDAC independently of relative ratios and propose a potential classification. Materials and Methods: We included 153 treatment-naïve patients with PDAC confirmed by postoperative histopathology. Of these, n = 68 (44.4%) underwent curative surgery, whereas n = 85 (55.6%) received palliative treatment or underwent surgical biopsy only. SAMBA was applied using laboratory reference ranges and overall survival (OS; months) as the analytical context. Results: The subgroups defined according to laboratory reference ranges did not differ significantly in disease stage, grade, or resection status. Based on correlation analyses, Kaplan–Meier curves, and a classification and regression tree (CART) analysis of OS, we propose four blood count phenotypes: exhausted, lymphopenic, T2-low, and T2-high (median OS: 1.5 months, n = 22; 4.5 months, n = 12; 8.0 months, n = 25; and 10.0 months, n = 94, respectively). Conclusions: We propose the following preliminary interpretations of these phenotypes: exhausted, potentially associated with concomitant infection or marked inflammation; lymphopenic, characterized by a low lymphocyte count and potentially reduced antitumor immune activity; eosinopenic (T2-low), characterized by a relatively balanced inflammatory profile but limited T2-associated features; and eosinophilic (T2-high), characterized by no major abnormalities in the other blood count parameters and a more favorable prognosis. SAMBA is a transparent, readily interpretable algorithm that may help standardize and accelerate preliminary research in immuno-oncology.
- Open Access
Perioperative Thyroid-Metabolic Changes in Pancreatic Ductal Adenocarcinoma According to Surgical Management
Background: Pancreatic ductal adenocarcinoma (PDAC) is associated not only with tumor progression but also with profound metabolic and nutritional disturbances. Thyroid hormone homeostasis may reflect this systemic response; however, perioperative data in PDAC remain limited. We aimed to assess perioperative changes in thyroid-related parameters in patients with PDAC undergoing different types of surgical management and to explore their associations with nutritional, metabolic, and tumor-burden variables. Methods: We performed a retrospective single-center study including 101 patients with PDAC. Thyroid-related and metabolic laboratory parameters were assessed before surgery and again 4–6 weeks later. The analyzed variables included thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), free thyroxine (FT4), the FT3/FT4 ratio, albumin, total protein, glucose, insulin, HbA1c, lipid parameters, and CA 19-9. Patients were analyzed according to resectional versus non-resectional treatment and according to four procedure types. The primary endpoint was perioperative change in the FT3/FT4 ratio. Results: At baseline, resectional patients had significantly higher FT3 and FT3/FT4 ratio values and lower FT4 and CA 19-9 levels than non-resectional patients. In the whole cohort, FT3 and the FT3/FT4 ratio decreased significantly after treatment, whereas TSH increased, and FT4 remained unchanged. These endocrine changes occurred in parallel with significant declines in albumin, total protein, glucose, insulin, HbA1c, and HDL cholesterol, together with an increase in triglyceride levels. Baseline FT3 and FT3/FT4 ratios correlated positively with albumin and total protein and negatively with CA 19-9. Although perioperative changes did not differ significantly between resectional and non-resectional groups except for triglycerides, significant procedure-dependent differences were observed across the four surgical categories for FT3, FT4, TSH, and the FT3/FT4 ratio; glucose; insulin; and triglycerides. The prevalence of low-T3 syndrome increased from 11.1% preoperatively to 38.7% postoperatively. Conclusions: In PDAC, perioperative changes in thyroid hormone indices are pronounced and strongly depend on the type of surgical management. FT3 and the FT3/FT4 ratio appear to reflect systemic metabolic and nutritional adaptation as well as disease burden rather than acting as tumor-specific markers.
Open AccessPerioperative Thyroid-Metabolic Changes in Pancreatic Ductal Adenocarcinoma According to Surgical Management
Background: Pancreatic ductal adenocarcinoma (PDAC) is associated not only with tumor progression but also with profound metabolic and nutritional disturbances. Thyroid hormone homeostasis may reflect this systemic response; however, perioperative data in PDAC remain limited. We aimed to assess perioperative changes in thyroid-related parameters in patients with PDAC undergoing different types of surgical management and to explore their associations with nutritional, metabolic, and tumor-burden variables. Methods: We performed a retrospective single-center study including 101 patients with PDAC. Thyroid-related and metabolic laboratory parameters were assessed before surgery and again 4–6 weeks later. The analyzed variables included thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), free thyroxine (FT4), the FT3/FT4 ratio, albumin, total protein, glucose, insulin, HbA1c, lipid parameters, and CA 19-9. Patients were analyzed according to resectional versus non-resectional treatment and according to four procedure types. The primary endpoint was perioperative change in the FT3/FT4 ratio. Results: At baseline, resectional patients had significantly higher FT3 and FT3/FT4 ratio values and lower FT4 and CA 19-9 levels than non-resectional patients. In the whole cohort, FT3 and the FT3/FT4 ratio decreased significantly after treatment, whereas TSH increased, and FT4 remained unchanged. These endocrine changes occurred in parallel with significant declines in albumin, total protein, glucose, insulin, HbA1c, and HDL cholesterol, together with an increase in triglyceride levels. Baseline FT3 and FT3/FT4 ratios correlated positively with albumin and total protein and negatively with CA 19-9. Although perioperative changes did not differ significantly between resectional and non-resectional groups except for triglycerides, significant procedure-dependent differences were observed across the four surgical categories for FT3, FT4, TSH, and the FT3/FT4 ratio; glucose; insulin; and triglycerides. The prevalence of low-T3 syndrome increased from 11.1% preoperatively to 38.7% postoperatively. Conclusions: In PDAC, perioperative changes in thyroid hormone indices are pronounced and strongly depend on the type of surgical management. FT3 and the FT3/FT4 ratio appear to reflect systemic metabolic and nutritional adaptation as well as disease burden rather than acting as tumor-specific markers.